Further analysis showed that expression levels of CD47 in immune inhibitory T cells were much higher in BMRCC than those of primary ccRCC, and PD-1 inhibitor treatment could not decrease the CD47 expression (Fig. 7c and Supplementary Fig. 7a). The gene discussed is CD47; the disease is nonpapillary renal cell carcinoma.